文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

ICU中的甲状腺危象:一项回顾性多中心研究

Thyroid Storm in the ICU: A Retrospective Multicenter Study.
PubMed 文献 · Crit Care Med · 2020-01-01
一句话结论需ICU收治的甲状腺危象患者ICU病死率17%、6个月病死率22%,入ICU后48小时内发生心源性休克与ICU死亡独立相关(OR 9.43)。

这项回顾性、多中心、全国性研究纳入法国31个ICU在2000至2017年间收治的92例符合日本甲状腺协会「明确甲状腺危象」标准且至少有一个甲状腺危象相关器官衰竭的患者,描述其临床表现、管理及ICU内和6个月生存率。胺碘酮相关甲状腺毒症(30例,33%)和Graves病(24例,26%)是主要病因,32%患者入ICU前甲状腺功能亢进未知;胺碘酮使用(26%)和抗甲状腺药物停药(14%)是主要诱发因素,33%未找到诱因。38%患者在入ICU后48小时内发生心源性休克,ICU病死率17%,6个月病死率22%。多因素分析显示,不含心血管成分的序贯器官衰竭评估评分(OR 1.22;95%CI 1.03-1.46;P=0.025)和入ICU后48小时内发生心源性休克(OR 9.43;95%CI 1.77-50.12;P=0.008)与ICU死亡独立相关。

要点

  • 需ICU收治的甲状腺危象患者ICU病死率17%、入院后6个月病死率22%。
  • 38%的患者在入ICU后48小时内发生心源性休克,且与ICU死亡独立相关(OR 9.43;95%CI 1.77-50.12;P=0.008)。
  • 不含心血管成分的序贯器官衰竭评估评分与ICU死亡独立相关(OR 1.22;95%CI 1.03-1.46;P=0.025)。
  • 胺碘酮相关甲状腺毒症(33%)和Graves病(26%)是主要病因,32%患者入ICU前甲亢未知。
  • 胺碘酮使用(26%)和抗甲状腺药物停药(14%)是主要诱发因素,33%未找到诱因。

适用人群与场景

  • 法国31个ICU在2000至2017年间收治的、符合日本甲状腺协会「明确甲状腺危象」标准且至少有一个甲状腺危象相关器官衰竭的患者。

诊断标准与关键阈值

  • 纳入标准为日本甲状腺协会标准定义的「明确甲状腺危象」,且至少有一个甲状腺危象相关器官衰竭。

红旗征与不能漏的情况

  • 入ICU后48小时内发生心源性休克:38%患者出现,多因素分析显示与ICU死亡独立相关(OR 9.43;95%CI 1.77-50.12;P=0.008)。

研究设计与关键结果

  • 研究类型为回顾性、多中心、全国性研究,纳入法国31个ICU在2000至2017年间的92例患者。
  • 主要病因为胺碘酮相关甲状腺毒症(30例,33%)和Graves病(24例,26%),32%(29例)患者入ICU前甲亢未知。
  • 主要诱发因素为胺碘酮使用(24例,26%)和抗甲状腺药物停药(13例,14%),33%(30例)未找到诱因。
  • 38%(35例)患者在入ICU后48小时内发生心源性休克。
  • ICU病死率为17%,入院后6个月病死率为22%。
  • ICU死亡组更常需要血管升压药、体外膜氧合、肾脏替代治疗、机械通气和/或治疗性血浆置换。
  • 多因素分析显示,不含心血管成分的序贯器官衰竭评估评分(OR 1.22;95%CI 1.03-1.46;P=0.025)和入ICU后48小时内发生心源性休克(OR 9.43;95%CI 1.77-50.12;P=0.008)与ICU死亡独立相关。

证据类型、等级与局限

  • 证据类型:回顾性、多中心、全国性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,多器官衰竭和早期心源性休克似乎显著影响预后,提示应快速识别并积极管理。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Thyroid storm represents a rare but life-threatening endocrine emergency. Only rare data are available on its management and the outcome of the most severe forms requiring ICU admission. We aimed to describe the clinical manifestations, management and in-ICU and 6-month survival rates of patients with those most severe thyroid storm forms requiring ICU admission.

DESIGN: Retrospective, multicenter, national study over an 18-year period (2000-2017).

SETTING: Thirty-one French ICUs.

PATIENTS: The local medical records of patients from each participating ICU were screened using the International Classification of Diseases, 10th Revision. Inclusion criteria were "definite thyroid storm," as defined by the Japanese Thyroid Association criteria, and at least one thyroid storm-related organ failure.

MEASUREMENTS AND MAIN RESULTS: Ninety-two patients were included in the study. Amiodarone-associated thyrotoxicosis and Graves' disease represented the main thyroid storm etiologies (30 [33%] and 24 [26%] patients, respectively), while hyperthyroidism was unknown in 29 patients (32%) before ICU admission. Amiodarone use (24 patients [26%]) and antithyroid-drug discontinuation (13 patients [14%]) were the main thyroid storm-triggering factors. No triggering factor was identified for 30 patients (33%). Thirty-five patients (38%) developed cardiogenic shock within the first 48 hours after ICU admission. In-ICU and 6-month postadmission mortality rates were 17% and 22%, respectively. ICU nonsurvivors more frequently required vasopressors, extracorporeal membrane of oxygenation, renal replacement therapy, mechanical ventilation, and/or therapeutic plasmapheresis. Multivariable analyses retained Sequential Organ Failure Assessment score without cardiovascular component (odds ratio, 1.22; 95% CI, 1.03-1.46; p = 0.025) and cardiogenic shock within 48 hours post-ICU admission (odds ratio, 9.43; 1.77-50.12; p = 0.008) as being independently associated with in-ICU mortality.

CONCLUSIONS: Thyroid storm requiring ICU admission causes high in-ICU mortality. Multiple organ failure and early cardiogenic shock seem to markedly impact the prognosis, suggesting a prompt identification and an aggressive management.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Bourcier S, Coutrot M, Kimmoun A, et al. Thyroid Storm in the ICU: A Retrospective Multicenter Study. Crit Care Med. 2020. PMID: 31714398. doi:10.1097/CCM.0000000000004078

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。